Amarin Corp Plc (AMRN)

[jessellivermore]

HK...

I am also a clinician...I hope you do not think I am in disagreement..I was in private practice for forty plus years..The biggest issue that comes up is that if there are alternative drugs with the same label "Indications and
usage..That would be the case of Marine vascepa AND gen lovaza. State laws can mandate the cheaper brand is preferred and is lower tiered And the Tiering out of pocket expense can be very dramatic..Eg, Brand is tier 4 and the generic (or cheaper alternative is tier 1 or tier 2..The supplier can fill your request..but it can cost your patient a couple of hundred dollars a month..

Vascepa currently is a Unicorn..Because it is still under H-W exclusion period for the R-I indication...But at least for the present is not still under H-W for the Marine indication..Ie generics and others must respect Amarin's still valid patents covering the R-I indication..And even judge Du ruled that Amarin's F-I patents are still valid and even "encouraging" by the generics to use the drug for the R-I indication would be considered Infringement..Indirectly inducing doctors to use Gen Vascepa for the R-I label indications..

":>) JL